Midha Shallu, Hasan Ajmal, Dhingra Rajan, Garg Pramod Kumar
Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
J Gastroenterol Hepatol. 2017 Jan;32(1):270-277. doi: 10.1111/jgh.13410.
Abdominal pain is difficult to treat in patients with chronic pancreatitis (CP). Medical therapy including antioxidants has been shown to relieve pain of CP in the short-term. Our aim was to study the long-term results of optimized medical and interventional therapy for pain relief in patients with CP with a step-up approach.
All consecutive patients with CP were included prospectively in the study. They were treated medically with a well-balanced diet, pancreatic enzymes, and antioxidants (9000 IU beta-carotene, 0.54 g vitamin C, 270 IU vitamin E, 600 µg organic selenium, and 2 g methionine). Endoscopic therapy and/or surgery were offered if medical therapy failed. Pain relief was the primary outcome measure.
A total of 313 patients (mean age 26.16 ± 12.17; 244 males) with CP were included; 288 (92%) patients had abdominal pain. The etiology of CP was idiopathic in 224 (71.6%) and alcohol in 82 (26.2%). At 1-year follow-up, significant pain relief was achieved in 84.7% of patients: 52.1% with medical therapy, 16.7% with endoscopic therapy, 7.6% with surgery, and 8.3% spontaneously. The mean pain score decreased from 6.36 ± 1.92 to 1.62 ± 2.10 (P < 0.001). Of the 288 patients, 261, 218, 112, and 51 patients were followed up for 3, 5, 10, and 15 years, respectively; 54.0%, 57.3%, 60.7%, and 68.8% of them became pain free at those follow-up periods.
Significant pain relief is achieved in the majority of patients with optimized medical and interventional treatment.
慢性胰腺炎(CP)患者的腹痛难以治疗。包括抗氧化剂在内的药物治疗已被证明可在短期内缓解CP患者的疼痛。我们的目的是采用逐步递进的方法研究优化药物和介入治疗缓解CP患者疼痛的长期效果。
所有连续性CP患者均前瞻性纳入本研究。他们接受了均衡饮食、胰酶和抗氧化剂(9000国际单位β-胡萝卜素、0.54克维生素C、270国际单位维生素E、600微克有机硒和2克蛋氨酸)的药物治疗。如果药物治疗失败,则提供内镜治疗和/或手术治疗。疼痛缓解是主要结局指标。
共纳入313例CP患者(平均年龄26.16±12.17岁;男性244例);288例(92%)患者有腹痛。CP的病因在224例(71.6%)中为特发性,82例(26.2%)为酒精性。在1年随访时,84.7%的患者疼痛得到显著缓解:药物治疗缓解的占52.1%,内镜治疗缓解的占16.7%,手术治疗缓解的占7.6%,自发缓解的占8.3%。平均疼痛评分从6.36±1.92降至1.62±2.10(P<0.001)。288例患者中,分别有261例、218例、112例和51例患者接受了3年、5年、10年和15年的随访;在这些随访期内,他们中分别有54.0%、57.3%、60.7%和68.8%的患者疼痛消失。
大多数CP患者通过优化的药物和介入治疗可实现显著的疼痛缓解。